PURA VIDA INVESTMENTS, LLC - Q1 2020 holdings

Add to watchlist

$842 Million is the total value of PURA VIDA INVESTMENTS, LLC's 93 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 100.0% .

All

			Value		Shares		↓ Weighting
HEXO	Exit	HEXO CORPput	$0	–	-150,000	-100.0%	-0.02%	–
APLT	Exit	APPLIED THERAPEUTICS INC	$0	–	-21,810	-100.0%	-0.05%	–
SPPI	Exit	SPECTRUM PHARMACEUTICALS INCcall	$0	–	-218,000	-100.0%	-0.07%	–
ALKS	Exit	ALKERMES PLC	$0	–	-54,000	-100.0%	-0.10%	–
QURE	Exit	UNIQURE NV	$0	–	-16,350	-100.0%	-0.10%	–
NVAX	Exit	NOVAVAX INCcall	$0	–	-327,800	-100.0%	-0.12%	–
DERM	Exit	DERMIRA INC	$0	–	-110,350	-100.0%	-0.15%	–
NTRA	Exit	NATERA INCcall	$0	–	-54,000	-100.0%	-0.16%	–
KALA	Exit	KALA PHARMACEUTICALS INC	$0	–	-533,287	-100.0%	-0.17%	–
RCM	Exit	R1 RCM INCcall	$0	–	-163,000	-100.0%	-0.19%	–
CABA	Exit	CABALETTA BIO INC	$0	–	-154,792	-100.0%	-0.19%	–
RCKT	Exit	ROCKET PHARMACEUTICALS INC	$0	–	-109,000	-100.0%	-0.22%	–
NTRA	Exit	NATERA INC	$0	–	-76,300	-100.0%	-0.23%	–
IOVA	Exit	IOVANCE BIOTHERAPEUTICS INCcall	$0	–	-109,000	-100.0%	-0.26%	–
HCA	Exit	HCA HEALTHCARE INCput	$0	–	-22,000	-100.0%	-0.29%	–
FLDM	Exit	FLUIDIGM CORP DEL	$0	–	-1,090,830	-100.0%	-0.33%	–
MASI	Exit	MASIMO CORP	$0	–	-24,409	-100.0%	-0.34%	–
HZNP	Exit	HORIZON THERAPEUTICS PUB Lcall	$0	–	-109,000	-100.0%	-0.35%	–
BYND	Exit	BEYOND MEAT INCput	$0	–	-54,000	-100.0%	-0.36%	–
QGEN	Exit	QIAGEN NV	$0	–	-124,780	-100.0%	-0.37%	–
MMSI	Exit	MERIT MED SYS INCcall	$0	–	-142,000	-100.0%	-0.39%	–
CI	Exit	CIGNA CORP NEWput	$0	–	-22,000	-100.0%	-0.40%	–
AXNX	Exit	AXONICS MODULATION TECHNOLOG	$0	–	-163,490	-100.0%	-0.40%	–
EXAS	Exit	EXACT SCIENCES CORPput	$0	–	-50,000	-100.0%	-0.41%	–
MJ	Exit	ETF MANAGERS TRcall	$0	–	-300,000	-100.0%	-0.45%	–
GH	Exit	GUARDANT HEALTH INCcall	$0	–	-66,000	-100.0%	-0.45%	–
CNMD	Exit	CONMED CORP	$0	–	-46,330	-100.0%	-0.46%	–
CGC	Exit	CANOPY GROWTH CORPput	$0	–	-300,000	-100.0%	-0.56%	–
OMCL	Exit	OMNICELL COMput	$0	–	-79,000	-100.0%	-0.57%	–
SDC	Exit	SMILEDIRECTCLUB INCput	$0	–	-820,000	-100.0%	-0.63%	–
GKOS	Exit	GLAUKOS CORPput	$0	–	-132,000	-100.0%	-0.63%	–
BCRX	Exit	BIOCRYST PHARMACEUTICALS INC	$0	–	-2,179,950	-100.0%	-0.66%	–
DVA	Exit	DAVITA INCput	$0	–	-112,000	-100.0%	-0.74%	–
PKI	Exit	PERKINELMER INCput	$0	–	-94,000	-100.0%	-0.80%	–
CSII	Exit	CARDIOVASCULAR SYS INC DELput	$0	–	-218,000	-100.0%	-0.93%	–
NVRO	Exit	NEVRO CORPcall	$0	–	-92,000	-100.0%	-0.95%	–
QGEN	Exit	QIAGEN NVput	$0	–	-327,000	-100.0%	-0.97%	–
STAA	Exit	STAAR SURGICAL COput	$0	–	-327,000	-100.0%	-1.01%	–
ABT	Exit	ABBOTT LABSput	$0	–	-137,000	-100.0%	-1.05%	–
INSP	Exit	INSPIRE MED SYS INCcall	$0	–	-163,000	-100.0%	-1.06%	–
AGN	Exit	ALLERGAN PLC	$0	–	-69,750	-100.0%	-1.17%	–
GRFS	Exit	GRIFOLS S Asp adr rep b nvt	$0	–	-578,620	-100.0%	-1.18%	–
XENT	Exit	INTERSECT ENT INCcall	$0	–	-654,000	-100.0%	-1.43%	–
BAX	Exit	BAXTER INTL INCcall	$0	–	-205,500	-100.0%	-1.51%	–
ILMN	Exit	ILLUMINA INCcall	$0	–	-52,000	-100.0%	-1.52%	–
BHVN	Exit	BIOHAVEN PHARMACTL HLDG CO Lcall	$0	–	-327,000	-100.0%	-1.57%	–
NSTG	Exit	NANOSTRING TECHNOLOGIES INCcall	$0	–	-654,000	-100.0%	-1.60%	–
QGEN	Exit	QIAGEN NVcall	$0	–	-593,000	-100.0%	-1.76%	–
UNH	Exit	UNITEDHEALTH GROUP INCput	$0	–	-94,000	-100.0%	-2.43%	–
IHI	Exit	ISHARES TRput	$0	–	-109,000	-100.0%	-2.54%	–

Original filings

The following EDGAR filing(s) were analyzed to create this report:

View 13F-HR/A filed 2021-02-12

Signatures

The EDGAR filing(s) were signed by:

Alyssa Romano — Chief Compliance Officer and Chief Financial Officer

Top long-term holdings

Name	Quarters owned	Latest quarter owned	Max weighting
ICU MED INC	26	Q2 2023	4.2%
NANOSTRING TECHNOLOGIES INC	26	Q2 2023	3.3%
VIEWRAY INC	25	Q2 2023	3.2%
LIVANOVA PLC	23	Q3 2023	3.8%
ALEXION PHARMACEUTICALS INC	23	Q1 2021	4.3%
INSPIRE MED SYS INC	22	Q3 2023	3.7%
BOSTON SCIENTIFIC CORP	22	Q3 2022	4.8%
INVACARE CORP	22	Q3 2021	2.8%
ESTABLISHMENT LABS HLDGS INC	21	Q3 2023	5.0%
INTERSECT ENT INC	21	Q2 2021	2.6%

View PURA VIDA INVESTMENTS, LLC's complete holdings history.

Latest significant ownerships (13-D/G)

PURA VIDA INVESTMENTS, LLC Q1 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
Stryve Foods Holdings, LLC	April 19, 2023	1,470,649	5.6%
ICAD INC	March 15, 2023	1,277,214	5.0%
ESTABLISHMENT LABS HOLDINGS INC.	February 14, 2023	1,002,767	4.1%
Pulmonx Corp	February 14, 2023	1,216,258	3.2%
Quotient Ltd^{Sold out}	February 14, 2023	0	0.0%
Universe Pharmaceuticals INC^{Sold out}	February 14, 2023	0	0.0%
MedMen Enterprises, Inc.	April 29, 2022	139,755,072	21.4%
INVACARE CORP^{Sold out}	February 14, 2022	0	0.0%
MedAvail Holdings, Inc.	February 14, 2022	714,120	2.2%
TELA Bio, Inc.	February 14, 2022	564,120	3.9%

View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.

Latest filings

Type	Filed
13F-HR	2024-05-15
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
13F-HR	2024-02-13

View PURA VIDA INVESTMENTS, LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

The reported total value is incorrect (842148000.0 != 842147000.0)
The reported has been restated
The reported has been amended

Export PURA VIDA INVESTMENTS, LLC's holdings